Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis.
axon injury
complex IV
experimental demyelination
mitochondria
multiple sclerosis and neuroprotection
Journal
Neuropathology and applied neurobiology
ISSN: 1365-2990
Titre abrégé: Neuropathol Appl Neurobiol
Pays: England
ID NLM: 7609829
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
revised:
26
07
2022
received:
14
12
2021
accepted:
21
08
2022
pubmed:
2
10
2022
medline:
3
3
2023
entrez:
1
10
2022
Statut:
ppublish
Résumé
Axonal injury in multiple sclerosis (MS) and experimental models is most frequently detected in acutely demyelinating lesions. We recently reported a compensatory neuronal response, where mitochondria move to the acutely demyelinated axon and increase the mitochondrial content following lysolecithin-induced demyelination. We termed this homeostatic phenomenon, which is also evident in MS, the axonal response of mitochondria to demyelination (ARMD). The aim of this study is to determine whether ARMD is consistently evident in experimental demyelination and how its perturbation relates to axonal injury. In the present study, we assessed axonal mitochondrial content as well as axonal mitochondrial respiratory chain complex IV activity (cytochrome c oxidase or COX) of axons and related these to axonal injury in nine different experimental disease models. We used immunofluorescent histochemistry as well as sequential COX histochemistry followed by immunofluorescent labelling of mitochondria and axons. We found ARMD a consistent and robust phenomenon in all experimental disease models. The increase in mitochondrial content within demyelinated axons, however, was not always accompanied by a proportionate increase in complex IV activity, particularly in highly inflammatory models such as experimental autoimmune encephalomyelitis (EAE). Axonal complex IV activity inversely correlated with the extent of axonal injury in experimental disease models. Our findings indicate that ARMD is a consistent and prominent feature and emphasise the importance of complex IV activity in the context of ARMD, especially in autoimmune inflammatory demyelination, paving the way for the development of novel neuroprotective therapies.
Identifiants
pubmed: 36181265
doi: 10.1111/nan.12851
pmc: PMC10092519
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12851Subventions
Organisme : Medical Research Council
ID : MR/R001162/1
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : MEHTA/JUL17/948-795
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/N50192X/1
Pays : United Kingdom
Organisme : Multiple Sclerosis Society
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R35 NS097303
Pays : United States
Informations de copyright
© 2022 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
Références
Brain. 1997 Mar;120 ( Pt 3):393-9
pubmed: 9126051
Trends Mol Med. 2014 Mar;20(3):179-87
pubmed: 24369898
N Engl J Med. 1998 Jan 29;338(5):278-85
pubmed: 9445407
Acta Neuropathol. 1998 Aug;96(2):139-43
pubmed: 9705128
Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12851
pubmed: 36181265
J Neuropathol Exp Neurol. 2010 Apr;69(4):372-85
pubmed: 20448482
Sci Rep. 2016 Sep 14;6:33249
pubmed: 27624721
Brain. 2005 Jul;128(Pt 7):1649-66
pubmed: 15872019
J Neurosci Res. 2006 Jun;83(8):1533-9
pubmed: 16555298
Biochim Biophys Acta. 2011 May;1812(5):630-41
pubmed: 21295140
Ann Neurol. 2011 Mar;69(3):481-92
pubmed: 21446022
Nat Rev Neurosci. 2006 Dec;7(12):932-41
pubmed: 17115075
Am J Pathol. 2000 Oct;157(4):1365-76
pubmed: 11021839
Nat Med. 2011 Apr;17(4):495-9
pubmed: 21441916
Ann Neurol. 2013 Dec;74(6):815-25
pubmed: 24038279
J Virol. 1997 Apr;71(4):3228-35
pubmed: 9060686
Neuron. 2014 Dec 17;84(6):1183-90
pubmed: 25433639
J Biol Chem. 2006 Oct 20;281(42):31950-62
pubmed: 16920708
Brain. 2009 May;132(Pt 5):1161-74
pubmed: 19293237
Mult Scler Relat Disord. 2012 Jan;1(1):29-38
pubmed: 25876448
J Immunol. 2005 Sep 1;175(5):3025-32
pubmed: 16116190
J Mol Neurosci. 2015 Oct;57(2):166-75
pubmed: 26067430
Cell Immunol. 1999 Jun 15;194(2):186-93
pubmed: 10383821
Acta Neuropathol. 2014 Aug;128(2):247-66
pubmed: 24622774
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9953-8
pubmed: 24958879
J Neurosci Methods. 2010 Sep 30;192(1):115-20
pubmed: 20659500
Lancet Neurol. 2015 Feb;14(2):183-93
pubmed: 25772897
Elife. 2021 Feb 10;10:
pubmed: 33565962
Eur J Immunol. 2004 Jul;34(7):1839-48
pubmed: 15214032
Acta Neuropathol. 2020 Aug;140(2):143-167
pubmed: 32572598
Acta Neuropathol. 2006 Jun;111(6):539-47
pubmed: 16718350
Glia. 1999 Feb 1;25(3):216-28
pubmed: 9932868
Lancet Neurol. 2002 Aug;1(4):232-41
pubmed: 12849456
Brain. 2011 Jul;134(Pt 7):1901-13
pubmed: 21705418
Nat Med. 2014 Apr;20(4):443-9
pubmed: 24681598